MobiHealth News March 28, 2019
Laura Lovett

A new report from PwC predicts that new and proposed FDA regulations could open up doors for pharmaceutical companies looking to develop digital tools.
Within the last few years the FDA has undergone a metamorphosis when it comes to digital health regulations. Though many of these are not yet solidified, a recent report by PricewaterhouseCoopers(PwC) predicts that these changes could open new doors for pharmaceutical companies looking to jump into the digital arena.

“Changes made by the FDA have made it easier for digital health products to be cleared and approved, offering life sciences companies — and pharmaceutical companies in particular — the opportunity to accelerate approvals and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, FDA, Govt Agencies, Market Research, Pharma, Regulations, Technology, Trends
Related Articles:
2023 Had Most Food Recalls Since Start Of COVID-19 Pandemic, Report Finds
FDA launches initiative to advance home healthcare models, devices
FDA Drug Approval Marks a New Day for Treating Pediatric Brain Cancer
FDA initiative puts AR/VR at heart of home health drive
Understanding the Value of the Home as a Healthcare Site

Share This Article